Caspase cleavage enhances the apoptosis-inducing effects of BAD

Molecular and Cellular Biology

Volumn 21, Issue 9, 2001, Pages 3025-3036

  Condorelli, F ^a   Salomoni, P ^a   Cotteret, S ^a   Cesi, V ^a   Srinivasula, S M ^a   Alnemri, E S ^a   Calabretta, B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CASPASE; CYTOCHROME C; FAS ANTIBODY; INTERLEUKIN 3; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; BINDING SITES; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL SURVIVAL; CULTURE MEDIA; CYTOCHROME C GROUP; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; JURKAT CELLS; MICE; MITOCHONDRIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBCELLULAR FRACTIONS;

ANIMALIA; MURINAE;

EID: 0035047712     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.9.3025-3036.2001     Document Type: Article

References (54)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Protein phosphatase 1alpha is a Ras-activated BAD phosphatase that regulates interleukin-2 deprivation-induced apoptosis
3. Granzyme B short-circuits the need for caspase-8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly clearing Bid
4. Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver
5. Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress-induced apoptosis
6. Conversion of Bcl-2 to a Bax-like death effector by caspases
7. Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation
8. L through caspase interaction
9. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
10. 14-3-3 Proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
11. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
12. 2+ ions
13. L
14. Apoptosis: A bad kinase makes good
15. Mitochondria and apoptosis
16. BCL-2 family members and the mitochondria in apoptosis
17. Serine-70 is one of the critical sites for drug-induced Bcl-2 phosphorylation in cancer cells
18. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
19. L/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11
20. Bax directly induces release of cytochrome c from isolated mitochondria
21. Bad is a BH3 domain-containing protein that forms an inactive dimer with Bcl-XL
22. Activation of membrane-associated procaspase-3 is regulated by Bcl-2
23. The mitochondrial death/life regulator in apoptosis and necrosis
24. Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis
25. BID, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
26. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling
27. Checkpoints of dueling dimers foil death wishes
28. Dimerization properties of human BAD. Identification of a B domain and analysis of its binding to mutant BCL-2 and BCL proteins
29. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidyl-inositide-3-OH kinase-dependent pathway
30. Efficient and rapid induction of a chronic myelogenous leukemia myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
31. Expression of constitutively active Raf-1 in the mitochondria restores anti-apoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant
32. Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects
33. Caspases: Intracellular signaling by proteolysis
34. Two CD45 (APO-1/FAS) signaling pathways
35. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and taxol-induced growth arrest
36. Dissociation of cytokine-induced phosphorylation of BAD and activation of PKB/Akt: Involvement of BAD upstream of BAD phosphorylation
37. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
38. Pro-apoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and directly modulate voltage-dependent anion channel activity
39. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
40. Molecular characterization of mitochondrial apoptosis-inducing factor
41. Mitochondrial release of caspase-2 and -9 during the apoptotic process
42. L interaction and cell survival
43. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
44. Bcl-2 targets the protein kinase Raf-1 to mitochondria
45. 2+-induced apoptosis through calcineurin dephosphorylation of BAD
46. BID: A novel BH3 domain-only death agonist
47. Cleavage of Bax enhances its cell death function
48. L and Bcl-2, displaces Bax and promotes cell death
49. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
50. Constitutive synthesis of interleukin-3 by leukemia cell line WEHI-3B is due to retroviral insertion near the gene
51. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
52. L
53. L and pro-apoptotic activity
54. Growth factors inactivate the cell death, BAD, by phosphorylation of its BH3 domain on serine 155